192 related articles for article (PubMed ID: 3707847)
21. P-glycoprotein expression and modulation of cell-membrane morphology in adriamycin-resistant P388 leukemia cells.
Radel S; Fredericks W; Mayhew E; Baker R
Cancer Chemother Pharmacol; 1990; 25(4):241-6. PubMed ID: 1967228
[TBL] [Abstract][Full Text] [Related]
22. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.
Ramu A; Glaubiger D; Fuks Z
Cancer Res; 1984 Oct; 44(10):4392-5. PubMed ID: 6467200
[TBL] [Abstract][Full Text] [Related]
23. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
24. Exploring multidrug resistance using rhodamine 123.
Kessel D
Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
[TBL] [Abstract][Full Text] [Related]
25. Chemosensitivity of drug-sensitive and drug-resistant P388 leukemia cell lines after hyperthermic treatment.
Toffoli G; Bevilacqua C; Franceschin A; Boiocchi M
J Chemother; 1989 Jul; 1(4 Suppl):1159-61. PubMed ID: 16312815
[No Abstract] [Full Text] [Related]
26. Cell surface alterations in murine leukaemia P388 adriamycin-resistant cells: studies on lectin-induced agglutination and rearrangement of lectin receptors.
Basrur VS; Chitnis MP; Menon RS
Oncology; 1985; 42(5):328-31. PubMed ID: 4034147
[TBL] [Abstract][Full Text] [Related]
27. Freeze-fracture study of plasma membranes in wild type and daunorubicin-resistant Ehrlich ascites tumor and P388 leukemia cells.
Sehested M; Simpson D; Skovsgaard T; Buhl-Jensen P
Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(5):327-35. PubMed ID: 2565630
[TBL] [Abstract][Full Text] [Related]
28. Calcium, calmodulin, and protein content of adriamycin-resistant and -sensitive murine leukemic cells.
Nair S; Samy TS; Krishan A
Cancer Res; 1986 Jan; 46(1):229-32. PubMed ID: 3940193
[TBL] [Abstract][Full Text] [Related]
29. [Effect of harringtonine and homoharringtonine on the traverse of cell cycle of P388 leukemic cells by flow cytometry].
Xue SB; Xu P; Li SW; Hu YY; Xiao JJ; Han R; Feng JB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Feb; 6(1):28-31. PubMed ID: 6238691
[No Abstract] [Full Text] [Related]
30. Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia.
Inaba M; Johnson RK
Cancer Res; 1977 Dec; 37(12):4629-34. PubMed ID: 922743
[TBL] [Abstract][Full Text] [Related]
31. Modulation of doxorubicin-induced chromosomal damage by calmodulin inhibitors and its relationship to cytotoxicity in progressively doxorubicin-resistant tumor cells.
Ganapathi R; Grabowski D; Hoeltge G; Neelon R
Biochem Pharmacol; 1990 Oct; 40(7):1657-62. PubMed ID: 2222519
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
Tsuruo T; Oh-Hara T; Sudo Y; Naito M
Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
[TBL] [Abstract][Full Text] [Related]
33. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
Chou TH; Kessel D
Biochem Pharmacol; 1981 Nov; 30(22):3134-6. PubMed ID: 6950722
[No Abstract] [Full Text] [Related]
34. Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells.
Capranico G; De Isabella P; Penco S; Tinelli S; Zunino F
Cancer Res; 1989 Apr; 49(8):2022-7. PubMed ID: 2702645
[TBL] [Abstract][Full Text] [Related]
35. Probing membrane alterations associated with anthracycline resistance using fluorescent dyes.
Kessel D
Biochem Pharmacol; 1988 Nov; 37(22):4253-6. PubMed ID: 3196354
[TBL] [Abstract][Full Text] [Related]
36. [Cytological characteristics of carminomycin-resistant P-388 lymphoid leukosis].
Kozinets GI; Ivanova E; Kuznetsova TV; Khanykova OK; Levina NV
Eksp Onkol; 1985; 7(4):60-4, 76. PubMed ID: 4042959
[TBL] [Abstract][Full Text] [Related]
37. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
Ramu A; Fuks Z; Gatt S; Glaubiger D
Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
[TBL] [Abstract][Full Text] [Related]
38. Elevated pentose cycle and glucuronyltransferase in daunorubicin-resistant P388 cells.
Gessner T; Vaughan LA; Beehler BC; Bartels CJ; Baker RM
Cancer Res; 1990 Jul; 50(13):3921-7. PubMed ID: 2112982
[TBL] [Abstract][Full Text] [Related]
39. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
Inaba M; Kobayashi H; Sakurai Y; Johnson RK
Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418
[TBL] [Abstract][Full Text] [Related]
40. Effect of hyperthermia on intracellular drug accumulation and chemosensitivity in drug-sensitive and drug-resistant P388 leukaemia cell lines.
Toffoli G; Bevilacqua C; Franceschin A; Boiocchi M
Int J Hyperthermia; 1989; 5(2):163-72. PubMed ID: 2926183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
